Department of Health (2004) Quality and Outcomes Framework: Guidance. London: Department of Health.
Department of Health (2006a) Models of Care for Alcohol Misusers (MoCAM). London: The Stationery Office.
Department of Health (2006b) Vocational Services for People with Severe Mental Health Problems: Commissioning Guidance. London: CSIP for Department of Work and Pensions and Department of Health.
Department of Health (2010) Fulfilling and Rewarding Lives: the Strategy for Adults with Autism in England. London: Department of Health. Available at: www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAnd Guidance/DH_113369
D’Eufemia, P., Celli, M., Finocchiaro, R., et al. (1996) Abnormal intestinal permeability in children with autism. Acta Paediatrica, 85, 1076–1079.
De Vries, A. L. C., Noens, I. L. J., Cohen-Kettenis, P. T., et al. (2010) Autism spectrum disorders in gender dysphoric children and adolescents. Journal of Autism and Developmental Disorders, 40, 930–936.
De Wied, D., Diamant, M. & Fodor, M. (1993) Central nervous system effects of the neurohypophyseal hormones and related peptides. Frontiers in Neuroendocrinology, 14, 251–302.
Dhumad, S. & Markar, D. (2007) Audit on the use of antipsychotic medication in a community sample of people with learning disability. The British Journal of Developmental Disabilities, 53, 47–51.
DiLavore, P. C., Lord, C. & Rutter, M. (1995) The pre-linguistic autism diagnostic observation schedule. Journal of Autism and Developmental Disorders, 25, 355–379.
Di Simplicio, M., Massey-Chase, R., Cowen, P. J., et al. (2009) Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers. Journal of Psychopharmacology, 23, 241–248.
Domes, G., Heinrichs, M., Gläscherb, J., et al. (2007) Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biological Psychiatry, 62, 1187–1190.
Donaldson, Z. R. & Young, L. J. (2008) Oxytocin, vasopressin, and the neurogenetics of sociality. Science, 322, 900–904.
Donnelly, M., McGilloway, S., Mays, N., et al. (1996) One and two year outcomes for adults with learning disabilities discharged to the community. British Journal of Psychiatry, 168, 598–606.
Dosman, C., Drmic, I., Brian, J., et al. (2006) Ferritin as an indicator of suspected iron deficiency in children with autism spectrum disorder: prevalence of low serum ferritin concentration. Developmental Medicine and Child Neurology, 48, 1008–1009.
Dosman, C. F., Brian, J. A., Drmic, I. E., et al. (2007) Children with autism: effect of iron supplementation on sleep and ferritin. Pediatric Neurology, 36, 152–158.
Drago, F., Pedersen, C. A., Caldwell, J. D., et al. (1986) Oxytocin potently enhances novelty-induced grooming behaviour in the rat. Brain Research, 368, 287–295.
Dunn, M. E., Burbine, T., Bowers, C. A., et al. (2001) Moderators of stress in parents of children with autism. Community Mental Health Journal, 37, 39–52.
Dunn-Geier, J., Ho, H. H., Auersperg, E., et al. (2000) Effect of secretin on children with autism: a randomized controlled trial. Developmental Medicine and Child Neurology, 42, 796–802.
Dy, S. M., Garg, P., Nyberg, D., et al. (2005) Critical pathway effectiveness: assessing the impact of patient, hospital care, and pathway characteristics using qualitative comparative analysis. Health Services Research, 40, 499–516.
Dyson, L. L. (1993) Response to the presence of a child with disabilities: parental stress and family functioning over the time. American Journal on Mental Retardation, 98, 207–218.
Dziobek, I., Fleck, S., Kalbe, E., et al. (2006) Introducing MASC: a movie for the assessment of social cognition. Journal of Autism and Developmental Disorders, 36, 623–636.
Earley, C. J. (2003) Restless legs syndrome. New England Journal of Medicine, 348, 2103–2109.
Earley, C. J., Connor, J. R., Beard, J. L., et al. (2000) Abnormalities in CSF concentrations of ferritin and transferring in restless legs syndrome. Neurology, 54, 1698–1700.
Eberlin, M., McConnachie, G., Ibel, S., et al. (1993) Facilitated communication: a failure to replicate the phenomenon. Journal of Autism and Developmental Disorders, 23, 507–530.
Eccles, M., Freemantle, N. & Mason, J. (1998) North of England evidence based guideline development project: methods of developing guidelines for efficient drug use in primary care. British Medical Journal, 316, 1232#1235.
Ecker, C., Marquand, A., Mourão-Miranda, J., et al. (2010) Describing the brain in autism in five dimensions: magnetic resonance imaging-assisted diagnosis of autism spectrum disorder using a multiparameter classification approach. Journal of Neuroscience, 30, 10612–10623.
Edelson, S. M., Rimland, B., Berger, C. L., et al. (1998) Evaluation of a mechanical hand-support for facilitated communication. Journal of Autism and Developmental Disorders, 28, 153–157.
Editors of The Lancet (2010) Retraction – Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. The Lancet, 375, 445.
Edwards, D. J., Chugani, D. C., Chugani, H. T., et al. (2006) Pharmacokinetics of buspirone in autistic children. Journal of Clinical Pharmacology, 46, 508–514.
Ehlers, S. & Gillberg, C. (1993) The epidemiology of Asperger syndrome: a total population study. Journal of Child Psychology and Psychiatry, 34, 1327–1350.
Elia, M., Ferri, R., Musumeci, S. A., et al. (2000) Sleep in subjects with autistic disorder: a neurophysiological and psychological study. Brain Development, 22, 88–92.
Elliott, R. O., Jr., Hall, K. L. & Soper, H. V. (1991) Analog language teaching versus natural language teaching: generalization and retention of language learning for adults with autism and mental retardation. Journal of Autism and Developmental Disorders, 21, 433–447.
Emmerson, B., Frost, A., Fawcett, L., et al. (2006) Do clinical pathways really improve clinical performance in mental health settings? Australasian Psychiatry, 14, 395–398.
Ergüner-Tekinalp, B. & Akkök, F. (2004) The effects of a coping skills training programme on the coping skills, hopelessness, and stress levels of mothers of children with autism. International Journal for the Advancement of Counselling,26, 257–269.
Erickson, C. A., Posey, D. J., Stigler, K. A., et al. (2007) A retrospective study of memantine in children and adolescents with pervasive developmental disorders. Psychopharmacology, 191, 141–147.
Esbensen, A. J., Greenberg, J. S., Seltzer, M. M., et al. (2009) A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders. Journal of Autism and Developmental Disorders, 39, 1339–1349.
Evangeliou, A., Vlachonikolis, I., Mihailidou, H., et al. (2003) Application of a ketogenic diet in children with autistic behavior: pilot study. Journal of Child Neurology, 18, 113–118.
Evans-Lacko, S. E., Jarrett, M., McCrone, P., et al. (2008) Clinical pathways in psychiatry. The British Journal of Psychiatry, 193, 4–5.
Fairburn, C. G., Marcus, M. D. & Wilson, G. T. (1993) Cognitive behaviour therapy for binge eating and bulimia nervosa: a treatment manual. In Binge Eating: Nature, Assessment and Treatment (eds C. G. Fairburn & G. T. Wilson), pp. 361–404. New York, NY: Guilford Press.
Fatemi, S. H., Halt, A. R., Stary, J. M., et al. (2002) Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in the autistic parietal and cerebellar cortices. Biological Psychiatry, 52, 805–810.
Feldman, M. A., Ducharme, J. M. & Case, L. (1999) Using self-instructional pictorial manuals to teach child-care skills to mothers with intellectual disabilities. Behavior Modification, 23, 480–497.
Fenwick, E., Claxton, K. & Sculpher, M. (2001) Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Economics, 10, 779–787.
Findling, R. L. (2005) Pharmacological treatment of behavioural symptoms in autism and pervasive developmental disorders. Journal of Clinical Psychiatry, 66, 26–31.
Fischer, J. E., Bachmann, L. M. & Jaeschke, R. (2003) A readers’ guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Medicine, 29, 1043–1051.
Fischer-Shofty, M., Shamay-Tsoory, S. G., Harari, H., et al. (2010) The effect of intranasal administration of oxytocin on fear recognition. Neuropsychologia, 48, 179–184.
Fish, B. (1985) Children’s Psychiatric Rating Scale. Psychopharmacology Bulletin, 21, 753–770.
Folstein, S. & Rutter, M. (1977) Infantile autism: a genetic study of 21 twin pairs. Journal of Child Psycholology and Psychiatry, 18, 297–321.
Fombonne, E. (2008) Thimerosal disappears but autism remains. Archives of General Psychiatry, 65, 15–16.
Francis, P. T., Palmer, A. M., Snape, M., et al. (1999) The cholinergic hypothesis of Alzheimer’s disease: a review of progress. Journal of Neurology, Neurosurgery and Psychiatry, 66, 137–147.
Freeman, B. J., Ritvo, E. R., Yokota, A., et al. (1986) A scale for rating symptoms of patients with the syndrome of autism in real life settings. Journal of the American Academy of Child Psychiatry, 25, 130–136.
Freeman, J. M., Kossoff, E. H. & Hartman, A. L. (2007) The ketogenic diet: one decade later. Pediatrics, 119, 535–543.
Fremeau, R. T., Jr., Jensen, R. T., Charlton, C. G., et al. (1983) Secretin: specific binding to rat brain membranes. Journal of Neuroscience, 3, 1620–1625.
Frith, U. (1989) Autism: Explaining the Enigma. Oxford: Basil Blackwell.
Frith, U. (1991) Autism and Asperger’s Syndrome. Cambridge: Cambridge University Press.
Furukawa, T. A., Barbui, C., Cipriani, A., et al. (2006) Imputing missing standard deviations in meta-analyses can provide accurate results. Journal of Clinical Epidemiology, 59, 7–10.
Fyson, R. & Kitson, D. (2007) Independence or protection – does it have to be a choice? Reflections on the abuse of people with learning disabilities in Cornwall. Critical Social Policy, 27, 426–436.
Gadow, K. D., DeVincent, C. J., Pomeroy, J., et al. (2004) Psychiatric symptoms in preschool children with PDD and clinic and comparison samples. Journal of Autism and Developmental Disorders, 34, 379–393.
Gadow, K. D., DeVincent, C. J., Pomeroy, J., et al. (2005) Comparison of DSM-IV symptoms in elementary school-age children with PDD versus clinic and community samples. Autism, 9, 392–415.
Gagiano, C., Read, S., Thorpe, L., et al. (2005) Short- and long-term efficacy and safety of risperidone in adults with disruptive behaviour disorders. Psychopharmacology, 179, 629–636.
Galli-Carminetti, G., Chauvet, I. & Deriaz, N. (2006) Prevalence of gastrointestinal disorders in adult clients with pervasive developmental disorders. Journal of Intellectual Disability Research, 50, 711–718.
Ganz, M. L. (2006) The cost of autism. In Understanding Autism: From Basic Neuroscience to Treatment (eds J. Rubenstein & S. Moldin), pp. 1–23. Boca Raton, FL: CRC Press.
Ganz, M. L. (2007) The lifetime distribution of the incremental societal costs of autism. Archives of Paediatrics and Adolescent Medicine, 161, 343–349.
García-Villamsiar, D. A. & Dattilo, J. (2010) Effects of a leisure programme on quality of life and stress of individuals with ASD. Journal of Intellectual Disability Research, 54, 611–619.
García-Villamisar, D. & Dattilo, J. (2011) Social and clinical effects of a leisure programme on adults with autism spectrum disorder. Research in Autism Spectrum Disorders, 5, 246–253.
García-Villamisar, D. & Hughes, C. (2007) Supported employment improves cognitive performance in adults with autism. Journal of Intellectual Disability Research, 51, 142–150.
García-Villamisar, D., Ross, D. & Wehman, P. (2000) Clinical differential analysis of persons with autism in a work setting: a follow-up study. Journal of Vocational Rehabilitation, 14, 183–185.
García-Villamisar, D., Wehman, P. & Diaz Navarro, M. (2002) Changes in the quality of autistic people’s life that work in supported and sheltered employment. A 5-year follow-up study. Journal of Vocational Rehabilitation, 17, 309–312.
García-Villamisar, D., Rojahn, J., Zaja, R. H., et al. (2010) Facial emotion processing and social adaptation in adults with and without autism spectrum disorder. Research in Autism Spectrum Disorders, 4, 755–762.
Gask, L., Usherwood, T., Thompson, H., et al. (1998) Evaluation of a training package in the assessment and management of depression in primary care. Medical Education, 32, 190–198.
Gaskell, G., Dockrell, J. & Rehman, H. (1995) Community care for people with challenging behaviours and mild learning disability: an evaluation of an assessment and treatment unit. British Journal of Clinical Psychology, 34, 383–395.
Gaus, V. (2000) “I feel like an alien’’: individual psychotherapy for adults with Asperger’s disorder using a cognitive behavioral approach. NADD Bulletin, 3, 62–65.
Gaus, V. L. (2007) Cognitive-Behavioral Therapy for Adult Asperger Syndrome. New York, NY: Guilford Press.
Geier, M. & Geier, D. (2005) The potential importance of steroids in the treatment of autistic spectrum disorders and other disorders involving mercury toxicity. Medical Hypotheses, 64, 946–54.
Geier, D. A. & Geier, M. R. (2006) A clinical trial of combined anti-androgen and anti-heavy metal therapy in autistic disorders. Neuroendocrinology Letters, 27, 833–838.
Geschwind, D. H. (2008). Autism: many genes, common pathways? Cell, 135, 391–395. Ghaziuddin, M. & Greden, J. (1998) Depression in children with autism/pervasive developmental disorders: a case-control family history study. Journal of Autism and Developmental Disorders, 28, 111–115.
Ghaziuddin, M., Ghaziuddin, N. & Greden, J. (2002) Depression in persons with autism: implications for research and clinical care. Journal of Autism and Developmental Disorders, 32, 299–306.
Gilbody, S., Bower, P., Fletcher, J., et al. (2006) Collaborative care for depression: a cumulative meta-analysis and review of longer term outcomes. Archives of Internal Medicine, 166, 2314–2321.
Gillberg, C. (1991) Clinical and neurobiological aspects of Asperger’s syndrome in six family studies. In Autism and Asperger’s Syndrome (ed. U. Frith), pp. 122–46. Cambridge: Cambridge University Press.
Gillberg, C. & Billstedt, E. (2000) Autism and Asperger syndrome: co-existence with other clinical disorders. Acta Psychiatrica Scandinavica, 102, 321–330.
Gillberg, C. & Coleman, M. (2000) The Biology of Autistic Syndromes (3rd edn). London: Cambridge University Press.
Gillberg, C., Rastam, M. & Wentz, E. (2001) The Asperger Syndrome (and high functioning autism) Diagnostic Interview (ASDI): a preliminary study of a new structured clinical interview. Autism, 5, 57–66.
Gillberg, I. C. & Gillberg, C. (1989) Asperger syndrome – some epidemiological considerations: a research note. Journal of Child Psychology and Psychiatry, 30, 631–638.
Gillot, A., Furniss, F. & Walter, A. (2001) Anxiety in high-functioning children with autism. Autism, 5, 277–286.
Gimpl, G. (2008) Oxytocin receptor ligands: a survey of the patent literature. Expert Opinion, 18, 1239–1251.
Gispen, W. H. (1980) On the neurochemical mechanism of action of ACTH. Progress in Brain Research, 53, 193–206.
Glaser, B. & Strauss, A. (1967). The Discovery of Grounded Theory: Strategies for Qualitative Research. New York: Aldine.
Goetz, J. P. & Lecompte, M. D. (1984) Ethnography and Qualitative Design in Educational Research. New York: Academic.
Golan, O. & Baron-Cohen, S. (2006) Systemizing empathy: teaching adults with Asperger syndrome or high-functioning autism to recognize complex emotions using interactive multimedia. Development and Psychopathology, 18, 591–617.
Golan, O., Baron-Cohen, S. & Hill, J. (2006) The Cambridge Mindreading (CAM) face-voice battery: testing complex emotion recognition in adults with and without Asperger syndrome. Journal of Autism and Developmental Disorders, 36, 169–183.
Goodman, W. K., Price, L. H., Rasmussen, S. A., et al. (1989a) The Yale-Brown Obsessive Compulsive Scale. I: development, use, and reliability. Archives of General Psychiatry, 46, 1006–1011.
Goodman, W. K., Price, L. H., Rasmussen, S. A., et al. (1989b) The Yale-Brown Obsessive Compulsive Scale. II: validity. Archives of General Psychiatry, 46, 1012–1016.
Goyette, C. H., Conners, C. K. & Ulrich, R. F. (1978) Normative data on revised Conners Parent and Teacher Rating Scales. Journal of Abnormal Child Psychology, 6, 221–236.
Graetz, J. E. (2010) Autism grows up: opportunities for adults with autism. Disability and Society, 25, 33–47.
Granpeesheh, D., Tarboxa, J., Dixon, D. R., et al. (2010) Randomized trial of hyperbaric oxygen therapy for children with autism. Research in Autism Spectrum Disorders, 4, 268–275.
Gray, D. E. (1998) Autism and the Family. Springfield, IL: Charles C. Thomas. Green, J., Gilchrist, A., Burton, D., et al. (2000) Social and psychiatric functioning in adolescents with Asperger syndrome compared with conduct disorder. Journal of Autism and Developmental Disorders, 30, 279–293.
Green, V. A., Pituch, K. A., Itchon, J., et al. (2006) Internet survey of treatments used by parents of children with autism. Research in Developmental Disabilities, 27, 70–84.
Greenhill, L. L., Swanson, J. M., Vitiello, B., et al. (2001) Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 180–187.
Gregory, S. G., Connelly, J. J., Towers, A., et al. (2009) Genomic and epigenetic evidence for OXTR deficiency in autism. BMC Medicine, 7, 62.
Gresham, F. M. & Elliot, S. N. (1990) Social Skills Rating System Manual. Circle Pines, MN: American Guidance Service.
Groden, J., Cautela, J. R., Prince, S., et al. (1994) The impact of stress and anxiety on individuals with autism and developmental disabilities. In: Behavioural Issues in Autism (eds E. Schopler & G. B. Mesibov), pp. 177–194. New York, NY: Plenum.
Gruenewald, T. L., Mroczek, D. K., Ryff, C. D., et al. (2008). Diverse pathways to positive and negative affect in adulthood and later life: an integrative approach using recursive partitioning. Developmental Psychology, 44, 330–343.
Gualtieri, C. T. (2002) Psychopharmacology of Brain Injured and Mentally Retarded Patients. Philadelphia, PA: Lippincott Williams and Wilkins.
Gualtieri, T., Chandler, M., Coons, T. B., et al. (1989) Amantadine: a new clinical profile for traumatic brain injury. Clinical Neuropharmacology, 12, 258–270.
Guastella, A. J., Mitchell, P. B. & Dadds, M. R. (2008) Oxytocin increases gaze to the eye region of human faces. Biological Psychiatry, 63, 3–5.
Guastella, A. J., Einfeld, S. L., Gray, K. M., et al. (2010) Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biological Psychiatry, 67, 692–694.
Guénolé, F., Godbout, R., Nicolautism, A., et al. (2011) Melatonin for disordered sleep in individuals with autism spectrum disorders: systematic review and discussion. Sleep Medicine Reviews, 15, 379–387.
Guy, W. (1976a) Clinical Global Impressions. In ECDEU Assessment Manual for Psychopharmacology, Revised (DHEW Publication No. ADM 76-338), pp. 218–222. Rockville, MD: National Institute of Mental Health (NIMH).
Guy, W. (1976b) Dosage Record and Treatment Emergent Symptoms scale (DOTES). In ECDEU Assessment Manual for Psychopharmacology, Revised (DHEW Publication No. ADM 76-338), pp. 223–244. Rockville, MD: NIMH.
Haas, R. H., Rice, M. A., Trauner, D. A., et al. (1986) Therapeutic effects of a ketogenic diet in Rett syndrome. American Journal of Medical Genetics, Suppl. 1, 225–246.
Hadwin, J., Baron-Cohen, S., Howlin, P., et al. (1995) Can we teach children with autism concepts of emotions, belief and pretence? Development and Psychopathology, 8, 345–365.
Haessler, F., Glaser, T., Beneke, M., et al. (2007) Zuclopenthixol in adults with intellectual disabilities and aggressive behaviours: discontinuation study. The British Journal of Psychiatry, 190, 447–448.
Hallett, V., Ronald, A. & Happe, F. (2009) Investigating the association between autistic-like and internalizing traits in a community-based twin sample. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 618–627.
Hallmayer, J., Cleveland, S., Torres, A., et al. (2011) Genetic heritability and shared environmental factors among twin pairs with autism. Archives of General Psychiatry, 68, 1095–1102.
Handen, B. L. & Hardan, A. Y. (2006) Open-label, prospective trial of olanzapine in adolescents with subaverage intelligence and disruptive behavioral disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 928–935.
Handen, B. L., Feldman, H., Gosling, A., et al. (1991) Adverse side effects of Ritalin among mentally retarded children with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 241–245.
Handen, B. J., Johnson, C. R. & Lubetsky, M. (2000) Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder. Journal of Autism and Developmental Disorders, 30, 245–255.
Haracopos, D. & Kelstrup, A. (1975) Psykotisk Adfærd [Psychotic Behaviour].Copenhagen: Så-materialer.
Hardan, A. Y., Jou, R. J. & Handen, B. L. (2004) A retrospective assessment of topiramate in children and adolescents with pervasive developmental disorders.Journal of Child and Adolescent Psychopharmacology, 14, 426–432.